Učitavanje...
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
BACKGROUND AND AIMS: The activating mutation BRAF(V600E) is a frequent genetic event in papillary thyroid carcinomas (PTC). Mutation BRAF(V600E) is associated with the loss of a sodium/iodine symporter (NIS), and subsequent radioiodide-refractory (RAI) metastatic disease. Use of BRAF V600E inhibitor...
Spremljeno u:
| Izdano u: | Thyroid Res |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6180498/ https://ncbi.nlm.nih.gov/pubmed/30337961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-018-0057-6 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|